ArticleFrontiers in oncology2023

Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways.

María José Besso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.